Genocea Biosciences, NMRC Sign Agreement To Co-develop Malaria Vaccine
As per the agreement, Genocea Biosciences will receive $2.7m from the US Army Medical Research and Materiel Command (USAMRMC) for rapid T-cell antigen discovery using human T-cell screens
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.